11/18/2020, 12:49 PM (Source: TeleTrader)
more TeleTrader news

Pfizer's final analysis shows 95% vaccine efficacy

Pfizer Inc. and BioNTech SE announced on Wednesday that their coronavirus vaccine candidate showed 95% efficacy in preventing the virus after final data analysis.

Meanwhile, the vaccine proved over 94% effective among elederly participants in late-stage trials who are at high risk of suffering from severe illness that may be caused by the virus.

Pfizer also unveiled that it intends to submit an application for emergency use authorization to the United States Food and Drug Administration (FDA) "within days." The US-based company and its German partner plan to manufacture 50 million doses of the vaccine this year and up to 1.3 billion doses in 2021.

Breaking the News / GA